NIH-funded researchers at the University of Texas at Austin engineered a compact, highly efficient CRISPR system, Al3Cas12f RKK, enabling targeted gene editing in the body.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
NIH-funded breakthrough shrinks CRISPR for precision delivery in the body | National Institutes of Health (NIH)
<10% To >80% improvement from
90% editing efficiency